Children’s Ibuprofen Recall: What Parents Necessitate to Know

Nearly 90,000 bottles of children’s ibuprofen oral suspension have been voluntarily recalled due to potential contamination with foreign substances, the U.S. Food and Drug Administration (FDA) announced. This recall impacts a common over-the-counter medication used to relieve pain and reduce fever in children.

What Product is Affected?

The recall specifically affects Children’s Ibuprofen Oral Suspension, a berry-flavored liquid medication recommended for children between the ages of 2 and 11 . The four-ounce (120 ml) bottles are manufactured by Strides Pharma Inc. In India for Taro Pharmaceuticals U.S.A., Inc. .

Why Was the Ibuprofen Recalled?

The recall was initiated after customers reported finding “a gel-like mass and black particles” within the bottles . Whereas the FDA has categorized the risk of serious health consequences as “remote,” the recall is a precautionary measure to ensure consumer safety .

Which Lot Codes and Expiration Dates are Affected?

The recalled products have lot codes 7261973A and 7261974A and an expiration date of 01/31/2027 .

What Should Parents Do?

Parents should immediately stop using the affected Children’s Ibuprofen Oral Suspension. The FDA advises consumers to :

• Contact your physician or healthcare provider if you have any concerns.
• Dispose of the recalled product safely.

Recall Classification

The FDA has classified this recall as a Class II recall, meaning that exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is remote .

Additional Information

The recall was initiated by Strides Pharma, the manufacturer of the medication . Taro Pharmaceuticals is a subsidiary of Sun Pharma . The recall number for the product is D-0390-2026 .